← All trials
NCT03915626
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2019
- Primary completion
- Feb 1, 2020
- Completion date
- Jun 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of MarylandLead sponsor
- Food and Drug AdministrationCollaborator
- University of MarylandReponsible party - principal investigator
- University of Maryland, Baltimore CountyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.